Renvela 800mg tablet

Renvela 800mg tablet contains Sevelamer Carbonate as its active ingredient. It belongs to the class of medications known as phosphate binders, primarily used for the management of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. Sevelamer Carbonate acts locally in the gastrointestinal tract, where it binds to dietary phosphate, preventing its absorption and thereby reducing serum phosphate levels. This helps in the control of hyperphosphatemia, which is commonly associated with CKD.

Key Features:

• Phosphate Binding Action: Sevelamer Carbonate binds to phosphate in the gastrointestinal tract, forming an insoluble complex that is excreted in the feces, thereby reducing phosphate absorption and serum phosphate levels.
• Dialysis Patients: Renvela 800mg tablet is indicated for use in patients with CKD on dialysis to manage elevated phosphate levels, which can contribute to complications such as mineral and bone disorders.
• Powder for Suspension: Renvela is also available in powder form for suspension, providing flexibility in dosing for patients who may have difficulty swallowing tablets.

Uses:

Renvela 800mg tablet is prescribed for:

• Hyperphosphatemia: Management of elevated phosphate levels in patients with CKD on dialysis.

Directions for Use:

• Renvela 800mg tablet should be taken orally with meals.
• Swallow the tablet whole with a sufficient amount of water; do not crush, chew, or break it.
• The dosage of Renvela may vary based on serum phosphate levels and individual patient requirements. Follow your healthcare provider’s instructions carefully.
• Ensure adequate hydration during treatment with Renvela to prevent constipation and ensure proper drug efficacy.

Precautions:

• Monitor serum phosphate levels regularly and adjust the dosage of Renvela as needed to maintain phosphate levels within the target range.
• Use caution in patients with a history of gastrointestinal disorders, including bowel obstruction, dysphagia, or severe constipation.
• Renvela may interfere with the absorption of certain medications; administer other oral medications at least one hour before or three hours after taking Renvela to avoid potential drug interactions.
• Inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking before starting treatment with Renvela.

Frequently Asked Questions (FAQs):

1. How should Renvela 800mg tablet be stored? Store Renvela tablets at room temperature away from moisture and heat. Keep the medication out of reach of children and pets.
2. Can Renvela 800mg tablet be crushed or chewed? No, Renvela tablets should be swallowed whole with water. Do not crush, chew, or break the tablets, as this may affect drug efficacy and increase the risk of adverse effects.
3. Are there any dietary restrictions while taking Renvela 800mg tablet? It is important to follow a balanced diet and adhere to any dietary recommendations provided by your healthcare provider while taking Renvela. Avoid foods high in phosphate to help control serum phosphate levels.
4. What are the common side effects of Renvela 800mg tablet? Common side effects of Renvela may include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. If these symptoms persist or worsen, contact your healthcare provider.
5. Can Renvela 800mg tablet be used during pregnancy or breastfeeding? Renvela should be used during pregnancy or breastfeeding only if the potential benefits outweigh the potential risks to the fetus or infant. Consult your healthcare provider before using this medication if you are pregnant, planning a pregnancy, or breastfeeding.